The Preeclampsia Foundation announced today that Merck for Mothers has awarded new funding for its program, MoMMAs Voices, a national coalition of patient advocacy organizations and individuals with "lived experience" – or those that represent them. Merck for Mothers is Merck’s global initiative to help create a world where no woman has to die while giving life.
With this new grant, MoMMAs Voices is preparing to engage hundreds of new patient and family partners (PFPs) across the U.S. in 2022. This program teaches both advocates and providers how to use the Lived Experience Integration™ framework to engage as partners wherever maternal health improvements are needed.
How the Lived Experience Integration™ and sharing of personal stories is making an impact:
The U.S. continues to face a maternal mortality crisis. According to the Centers for Disease Control and Prevention (CDC), at least 60% of these deaths are preventable. Black, Indigenous, and People of Color (BIPOC) are disproportionately affected. MoMMAs Voices is providing grant writing, execution, and reporting support specifically for BIPOC led organizations to build capacity to address this head-on. This effort will aim to increase BIPOC representation as patient and family partners nationwide.
“MoMMAs Voices breaks down silos between maternal health organizations to amplify lived patient experiences that represent the voices of the women and their families affected by maternal health conditions,” said Eleni Tsigas, chief executive officer of the Preeclampsia Foundation. “The continued funding of our patient-centric work ensures patients continue to have a role in addressing the U.S. maternal health crisis.”
About MoMMAs Voices
MoMMAs (Maternal Mortality and Morbidity Advocates) Voices is the first-ever maternal health patient advocacy coalition established in 2018, to amplify the voices of people who have experienced childbirth complications or loss - especially those who have been historically marginalized - ensuring they are equipped and activated as partners with providers and researchers to improve maternal health outcomes. This is a program of the Preeclampsia Foundation, a 501(c)(3) non-profit organization, and is supported by a grant through Merck for Mothers. For more information, visit www.mommasvoices.org and preeclampsia.org.
Melbourne, Fla. – June 27, 2024 – The Preeclampsia Foundation is seeking Letters of Intent for the Peter Joseph Pappas Research Grants funding program, designed to accelerate preeclampsia...
Program competes for one of four $200,000 grant prizes in 2025 MELBOURNE, Fla. – June 12, 2024 – The National Institutes of Health (NIH) announced today that the Preeclampsia Foundation&r...
The U.S. Department of Health and Human Services (HHS) Office on Women’s Health has announced that the Preeclampsia Foundation Cuff Kit™ program will be joining 10 other final phase winner...
North Bethesda, MD – February 10, 2024—The Foundation for the National Institutes of Health (FNIH) today announced the launch of a new public-private partnership to develop tools to identi...
January 25, 2024 – Melbourne, FL – The Preeclampsia Foundation welcomed a new group of officers to their 2024 Board of Directors today. Robyn D’Oria, MA, RNC, APN will serve as the n...